November is a very active month in our laboratory. Dr. Jutras-Aswad and colleagues will be presenting at the International Society of Addiction Medicine annual meeting the results of the OPTIMA study, a large scale national, multi-site, interventional study that evaluated the effectiveness of two models of care for the management of opioid-related disorders. The results of this study underscore the…

In collaboration with our national and international colleagues, we have just updated the lower-risk cannabis use guidelines according to the most recent evidence. Remember that the only way to avoid the harms associated with cannabis is to completely abstain from consuming it. For those who would like to consume it, it is safer to delay initiation of use as late…

The CHAMPS study begins this month at our partner site, the JAP clinic affiliated with the Centre hospitalier de l’Université de Montréal. This pilot clinical trial aims to assess the acceptability and efficacy of the new CHAMPS (Cannabis Harm-Reducing App for Managing Practices Safely) smartphone app aimed at reducing cannabis-related harms in 100 young cannabis users with psychotic disorders who…